longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Synergy CHC

SNYR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.26, below the reasonable range, cheaper than 86.59% of the time in the past 1 years, and the industry ranks 20/54, the industry Median -0.30.

-0.259xP/E
--Stock price
-0.259xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
5.15x
Typical range
-0.23x–8.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
04896144192

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
SSDOYUSShiseido
-67.66x--$8.87B
COTYUSCoty
-3.75x115.63%$2.32B
EPCUSEdgewell Personal Care
-13.52x85.53%$1.26B
GLASUSGlass House Brands
-10.52x--$673.83M
HNSTUSHonest
-46.57x166.37%$566.46M
USNAUSUSANA Health Sciences
-11.89x205.17%$263.48M
YSGUSYatsen
-7.73x34.23%$232.63M
NUSUSNu Skin
-1.04x248.43%$224.89M
MEDUSMedifast
-5.21x44.71%$133.27M
WALDUSWaldencast
-0.58x65.17%$132.11M
SKINUSSkinHealth
-3.02x8.39%$85.89M
UPXIUSUpexi
-0.33x--$81.62M
BHSTUSBioHarvest Sciences
-2.97x12.08%$32.87M
DQWSUSDSwiss, Inc.
-70.67x--$17.38M
DSYUSBig Tree Cloud
----$17.11M
HYEXUSHealthy Extracts Inc.
-18.45x--$16.22M
ZIVOUSZivo Bioscience
-1.76x--$14.95M
MTEXUSMannatech
-1.89x--$13.99M
CABRUSCaring Brands
-1.28x--$12.60M
BNKKUSBonk
-0.13x--$11.36M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.